Abstract
Genomic surveillance detected clonal Escherichia coli sequence type-361 isolates carrying blaNDM-5, blaKPC-3, blaCTX-M-15, and rmtB1 from a patient in Ukraine and four wounded foreign soldiers evacuated to Germany. Isolates were non-susceptible to carbapenems, aminoglycosides, and cefiderocol and aztreonam/avibactam due to a PBP3 YRIN insertion and the blaCMY-145 AmpC β-lactamase. Coordinated surveillance efforts across civilian, military, and veteran healthcare systems are essential to prevent further spread as international volunteers return home after medical evacuation from Ukraine.
Keywords:
Ukraine; antibiotic resistance; carbapenem resistance; genomic surveillance.
MeSH terms
-
Anti-Bacterial Agents* / pharmacology
-
Azabicyclo Compounds* / pharmacology
-
Aztreonam* / pharmacology
-
Bacterial Proteins / genetics
-
Cefiderocol*
-
Cephalosporins* / pharmacology
-
Cyclooctanes / pharmacology
-
Drug Resistance, Multiple, Bacterial / genetics
-
Escherichia coli Infections / drug therapy
-
Escherichia coli Infections / microbiology
-
Escherichia coli Proteins / genetics
-
Escherichia coli* / drug effects
-
Escherichia coli* / genetics
-
Germany
-
Humans
-
Microbial Sensitivity Tests*
-
Military Personnel
-
Ukraine / epidemiology
-
beta-Lactamases* / genetics
Substances
-
beta-Lactamases
-
Aztreonam
-
Azabicyclo Compounds
-
Anti-Bacterial Agents
-
Cephalosporins
-
Cefiderocol
-
Escherichia coli Proteins
-
beta lactamase NDM-5, E coli
-
Bacterial Proteins
-
avibactam
-
Cyclooctanes
-
AmpC beta-lactamases